Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Review Article Volume 6 Issue 1

CRISPER-CAS9 Utilization for HIV/AIDS Treatment

Chouia Yassine* and Amran Wafa

Department of Medicine, University of Amar Telidji, Algeria

*Corresponding Author: Chouia Yassine, Department of Medicine, University of Amar Telidji, Algeria.

Received: September 21, 2021; Published: December 09, 2021

Abstract

Human immunodeficiency virus is (HIV) is a disease responsible for HIV/AIDS. The virus attacks immune cells of the host organism which renders them uncapable of assuring their role of defence, !thus leading to the deficiency of the immune system against other pathologies.

While HIV has gained the interest of a lot of scientists and doctors who trying to cure it, none of the treatments has been approved as having a substantial effect that eliminates the virus from the host’s body. The current medications only allow the immune system to recover partially while the virus could be under suppression. As technologies develop, new ways of treatment that are more effective and efficient than normal medications are starting to catch the attention of both scientists and doctors alike. One of these fast developing technologies is genetic modification technology, using CRISPR CAS9. This paper concerns itself with the possible applications of CRISPR CAS9 in the treatment of HIV/AIDS.

 

Keywords: Human Immunodeficiency Virus (HIV); CRISPR CAS9; Immune Cells; Immune System

References

  1. https://hivinfo.nih.gov/understanding-hiv/fact-sheets/hiv-treatment-basics
  2. https://www.ncbi.nlm.nih.gov/books/NBK27142/
  3. https://www.researchgate.net/figure/Human-Immunodeficiency-Virus-Structure-of-HIV_fig3_44227364
  4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901762/
  5. “How to Select the Best CRISPR Transfection Protocol”.
  6. https://sites.tufts.edu/crispr/applications/hiv-treatment/
  7. Alexander G Allen., et al. “Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection”. Frontiers in Microbiology 9 (2018): 2940.
  8. Yue Yang., et al. “CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research”. Frontiers in Medicine (Lausanne) 8 (2021): 649896.

Citation

Citation: Chouia Yassine and Amran Wafa. “CRISPER-CAS9 Utilization for HIV/AIDS Treatment". Acta Scientific Medical Sciences 6.1 (2022): 99-108.

Copyright

Copyright: © 2022 Chouia Yassine and Amran Wafa. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 15, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US